Dermapharm SE Laborant bedient Maschine

Dermapharm Holding SE posts strong results for Q3 2024

Arkopharma (France) back above prior-year EBITDA levels for first time

Dermapharm - Pharmaceutical Excellence “Made in Europe”

Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals and healthcare products. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Europe (primarily in Germany) and the United States.

Read Interim Statement Q3 2024

Current Company Presentation

Comprehensive overview of the Dermapharm Group.

Dermapharm SE Icon Glasflasche

PHARMACEUTICAL INGREDIENTS

>390

Dermapharm SE Icon Bündel Geldscheine

REVENUE H1 2024

EUR 578.5 Mio. million

Dermapharm SE Icon Stift und Papier

MARKETING AUTHORISATIONS

>1,300

Dermapharm SE Icon steigender Aktienkurs

EBITDA H1 2024 (adjusted)

EUR 153.0 million

Reasons to invest

  1. Clear focus on Europe as a quality location
  2. High-growth pharmaceutical manufacturer in selected, profitable niche markets
  3. In-house R&D competence
  4. Pipeline with > 60 ongoing development projects
  5. Successful track record in acquisitions
  6. Expansion of international presence
Dermapharm SE Icon Glasflasche

PHARMACEUTICAL INGREDIENTS

>390

Dermapharm SE Icon Stift und Papier

MARKETING AUTHORISATIONS

>1,300

Dermapharm SE Icon Bündel Geldscheine

REVENUE H1 2024

EUR 578.5 Mio. million

Dermapharm SE Icon steigender Aktienkurs

EBITDA H1 2024 (adjusted)

EUR 153.0 million

Share

more details

Our brands and location

Find your way to our subsidiaries at different locations worldwide on a clearly arranged map!

Dermapharm SE Weltausschnitt Europa

IR Newsletter Service

We will be happy to include you in our news service!
Please fill out the form and you will receive information on investor relations topics.

Sustainability within the Dermapharm Group

Are you interested in sustainability? So are we! Read the details in our CSR report or find information on our investment in energy-efficient buildings or the resource-conserving use of raw materials directly under the highlights.

 

Dermapharm SE Photovoltaikanlage im Sonnenuntergang